南亞新材(688519.SH):變更部分募投項目實施主體、實施地點及實施方式並向子公司增資以實施募投項目
格隆匯 12 月 30日丨南亞新材(688519.SH)公佈,變更募投項目實施主體、實施地點及實施方式:公司募投項目“研發中心改造升級項目”部分內容的實施主體由公司變更為全資子公司南亞新材料技術(東莞)有限公司(待核準,“東莞南亞”),實施地點由上海市嘉定區南翔鎮昌翔路158號變更為廣東省東莞市松山湖園區,實施方式由自有產權房變更為租賃房產;
鑑於募投項目“研發中心改造升級項目”部分內容的實施主體由公司變更為東莞南亞,故以“研發中心改造升級項目”的募集資金人民幣2500萬元,向東莞南亞增資以實施變更部分募投項目。
此次部分募投項目涉及調整事項尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.